What is the active ingredient in Breyanzi?

Lisocabtagene maraleucel (lisocabtagenum maraleucelum)

What pharmaceutical form is Breyanzi available in?

Breyanzi: Dyspersja do infuzji 1,1–70 × 106 komórek/ml / 1,1–70 × 10 6 komórek/ml (dożylna)

Breyanzi requires a doctor's prescription.

Bristol-Myers Squibb Pharma EEIG (Holandia)

Breyanzi: ATC L01XL08. ATC is the WHO Anatomical Therapeutic Chemical classification.

1,1–70 × 106 komórek/ml / 1,1–70 × 10 6 komórek/ml, Dyspersja do infuzji

INN: Lisocabtagene maraleucel

Data updated: 2026-04-13

可购买国家:

🇨🇿🇩🇪🇬🇧🇵🇱🇵🇹🇸🇰

剂型

Dyspersja do infuzji

用法用量

1,1–70 × 106 komórek/ml / 1,1–70 × 10 6 komórek/ml

给药途径

dożylna

储存条件

—

关于本产品

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.